Event article view


Meet with us.

Lectures by our Vice President R&D, Dinja Oosterhoff, PhD.

Development of an inactivated EV D68 vaccine using Vero cell platform technology
Day 2 – 3 April 2024 – 2:40 PM Room 202B
Avacc 10: An intranasal Outer Membrane Vesicle based subunit vaccine for COVID 19
Day 2 – 3 April 2024 – 4:40 PM Room 207A

See more

Contact us

You can send us an email:

Reach out to Business Development: 

Or pick up the phone: 
+31 30 792 03 00

You can also just fill out the contact form on the right.

We look forward to hearing from you!


Contact form

Subscribe to our newsletter